New drugs in the management of small cell lung cancer

This publication has 16 references indexed in Scilit:

• Phase II Study of Carboplatin in Small Cell Lung Cancer
  Japanese Journal of Clinical Oncology, 1988
• The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay
  European Journal of Cancer and Clinical Oncology, 1988
• 4′-deoxydoxorubicin, an inactive drug in small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1987
• New drugs in small-cell lung cancer
  Cancer Treatment Reviews, 1986
• Small cell carcinoma of the lung
  Critical Reviews in Oncology/Hematology, 1986
• Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer
  Cancer Chemotherapy and Pharmacology, 1986
• Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
  The Journal of Experimental Medicine, 1985
• VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer
  Cancer, 1984
• Hexamethylmelamine as a single agent in the treatment of small-cell carcinoma of the lung
  American Journal of Clinical Oncology, 1982
• Vindesine trials at Memorial Sloan-Kettering Cancer Center
  Cancer Treatment Reviews, 1980